2‐Mercaptonicotinoyl glycine prevents UV ‐induced skin darkening and delayed tanning in healthy subjects: A randomized controlled clinical study
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16200 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von R de Dormael und 8 weiteren Autor:innen. Beteiligte Einrichtung: L'Oréal Research and Innovation, France. Hauptthemen laut MEDLINE: Ultraviolet Rays, Skin Pigmentation, Glycine. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Chronic nonextreme sun exposure induces two mechanisms of skin pigmentation, causing immediate darkening and delayed tanning. A new molecule, 2‐mercaptonicotinoyl glycine (2‐MNG), has been shown in vitro to inhibit both immediate darkening and new melanin synthesis via covalent conjugation of the thiol group of 2‐MNG to melanin precursors.
Objective
To evaluate 2‐MNG in preventing both mechanisms in vivo.
Methods
In a randomized, intra‐individual and controlled study, 33 subjects with melanin‐rich skin were exposed to UV daylight on designated areas on the back and treated with a cosmetic formula containing 0.5% or 1% 2‐MNG alone or 0.5% 2‐MNG in association with lipohydroxy acid (LHA, 0.3%) plus Mexoryl‐SX (MSX, 1.5%). The respective vehicles were used as controls and 4‐n‐butyl‐resorcinol (4‐n‐BR, 2.5%) as a positive reference.
Results
2‐MNG alone significantly reduced immediate darkening and inhibited new melanin production when compared with vehicle, with higher performance at 1% than at 0.5%. 2‐MNG at 0.5% in association with LHA and MSX showed significantly higher performance than 2‐MNG 0.5% alone. 2‐MNG at 0.5% and 1% showed significantly better performance than 4‐n‐BR.
Conclusions
2‐MNG inhibited both UV‐induced skin pigmentation mechanisms in vivo. The association of 2‐MNG with LHA plus MSX showed the highest efficacy on melanin‐rich skin with pigmentation induced by UV exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- L'Oréal Research and Innovation, France.
- L'Oréal Research and Innovation, Shanghai, China.
- L'Oréal Research and Innovation, Sakado, Takatsu-ku Kawasaki, Japan.
- L'Oréal Research and Innovation, Chembur, Mumbai, India.
ORCID-Profile: R de Dormael, P Sextius, N Bourokba, E Mainguene, R Tachon, K Gaurav, H Jouni, P Bastien, S Diridollou
Zitieren
APA
de Dormael, R., Sextius, P., Bourokba, N., Mainguene, E., Tachon, R., Gaurav, K., Jouni, H., Bastien, P., & Diridollou, S. (2024). 2‐Mercaptonicotinoyl glycine prevents UV ‐induced skin darkening and delayed tanning in healthy subjects: A randomized controlled clinical study. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16200
Vancouver
de Dormael R, Sextius P, Bourokba N, Mainguene E, Tachon R, Gaurav K, et al. 2‐Mercaptonicotinoyl glycine prevents UV ‐induced skin darkening and delayed tanning in healthy subjects: A randomized controlled clinical study. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16200
BibTeX
@article{deDormael2024,
author = {de Dormael, R and Sextius, P and Bourokba, N and Mainguene, E and Tachon, R and Gaurav, K and Jouni, H and Bastien, P and Diridollou, S},
title = {2‐Mercaptonicotinoyl glycine prevents UV ‐induced skin darkening and delayed tanning in healthy subjects: A randomized controlled clinical study},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16200}
}
EUVIMED